WallStSmart
CNTN

Canton Strategic Holdings, Inc.

NASDAQ: CNTN · HEALTHCARE · BIOTECHNOLOGY

$1.93
-5.39% today

Updated 2026-07-29

Market cap
$157.33M
P/E ratio
P/S ratio
EPS (TTM)
$-0.36
Dividend yield
52W range
$1 – $9
Volume
1.0M

WallStSmart proprietary scores

27
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C
6.3
Quality
B
3.0
Profitability
D
5.0
Valuation
C+
3/9
Piotroski F-Score
Weak
1.5
Altman Z-Score
Distress
Industry rank
View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target
12-Month target
Intrinsic (DCF)
Margin of safety

Price chart

Stock snapshot

Strengths
Insufficient data
Risks
- Piotroski 3/9 — weak financial health
- Altman Z 1.54 — distress zone
- Thin margins at 0.00%
- Negative free cash flow $-62.46M

Key financials

Revenue Net Income Free Cash Flow
Metric2022202320242025TTM
Revenue$0.00$0.00$0.00$0.00$0.00
Net income$-8.47M$-9.32M$-12.20M$-35.92M$-47.34M
EPS$-0.36
Free cash flow$-6.56M$-7.30M$-10.90M$-93.70M$-62.46M
Profit margin

Peer comparison

CompanyMkt CapScoreGrowthProfitValueQualityMoSRating
CNTN$157.33M274.33.05.06.3Avoid
LLY$1.02T7610.010.04.36.0Strong Buy
JNJ$615.36B574.78.54.36.0Buy
ABBV$447.53B634.08.04.75.0-78.83%Buy
UNH$391.69B627.35.54.06.0-30.51%Buy
MRK$307.25B503.38.02.75.0-62.28%Hold

Smart narrative

Canton Strategic Holdings, Inc. trades at $1.93. Our Smart Value Score of 27/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of 1.54, it sits in the distress.

Frequently asked questions

What is Canton Strategic Holdings, Inc.'s stock price?

Canton Strategic Holdings, Inc. (CNTN) trades at $1.93.

Is Canton Strategic Holdings, Inc. overvalued?

Canton Strategic Holdings, Inc. carries a Smart Value Score of 27/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

Altman Z-Score?

Canton Strategic Holdings, Inc.'s Altman Z-Score is 1.54, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.

Company info

SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD

Quick metrics

P/S ratio
ROE-34.40%
Beta1.44
50D MA$2.75
200D MA$3.22
Shares out0.08B
Float0.06B
Short ratio
Avg volume1.0M

Performance

1 week
1 month
3 months
YTD
1 year
3 years
5 years